Progyny (PGNY) Liabilities and Shareholders Equity (2018 - 2026)

Progyny (PGNY) has reported Liabilities and Shareholders Equity for 9 consecutive years, with $715.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 5.93% year-over-year to $715.8 million in Q2 2026; TTM through Jun 2026 was $3.0 billion, a 7.02% increase from a year earlier, with the FY2025 full-year figure at $742.4 million, up 22.29% from the prior year.
• Liabilities and Shareholders Equity was $715.8 million for Q2 2026 at Progyny, up from $698.3 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $795.2 million in Q3 2025 and troughed at $415.5 million in Q1 2022.
• A 5-year average of $663.9 million and a median of $698.5 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity soared 56.36% in 2023 and fell 19.76% in 2024, its largest moves.
• Over 5 years, Liabilities and Shareholders Equity stood at $543.0 million in 2022, then jumped by 39.34% to $756.6 million in 2023, then slipped by 19.76% to $607.1 million in 2024, then rose by 22.29% to $742.4 million in 2025, then dropped by 3.58% to $715.8 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $715.8 million (Q2 2026), $698.3 million (Q1 2026), and $742.4 million (Q4 2025), per Business Quant data.